Welcome to SynapCell

SynapCell is a preclinical Contract Research Organization which provides translational solutions to evaluate the therapeutic potential of CNS drug candidates in epilepsy. SynapCell provides customized solutions which cover the entire range of customers needs, from early steps to the final answer.

Services

synapcell_MTLE_mouse_in-vivo

In-vivo solutions

SynapCell assesses the effects of your drug candidates through predictive animal models of epilepsy, protocols mimicking clinical trials and quantitative results using EEG.

synapcell in-vivo solutions

In-vitro solutions

We define the activity profile of your drug candidates on neuronal networks through integrated models on acute / organotypic brain slices, with various experimental conditions and multisite recording using MEA

synapcell R&D programs and CNS drug development

Customized R&D programs

SynapCell helps you to improve and accelerate your R&D programs and CNS drug development.

What's new

Eleventh Eilat conference on new antiepileptic drugs Eilat, Israel, May 6 – 10, 2012

The conference program is designed to provide an in-depth progress report on new antiepileptic drugs in different stages of development, as well as to present new findings on second-generation treatments.
SynapCell will be presenting its chronic animal models of epilepsy and their particular adequation for drug development in the field during the poster session.

We will be happy to meet you there!
Feel free to contact us: +33 667 531 418

www.eilat-aeds.com/XI/